Potentiation of Bradykinin Actions by ACE Inhibitors (original) (raw)

Enhancement of Bradykinin and Resensitization of Its B2 Receptor

Peter Deddish

Hypertension, 1999

View PDFchevron_right

Replacement of the Transmembrane Anchor in Angiotensin I-converting Enzyme (ACE) with a Glycosylphosphatidylinositol Tail Affects Activation of the B2 Bradykinin Receptor by ACE Inhibitors

Peter Deddish

Journal of Biological Chemistry, 2000

View PDFchevron_right

Products of Angiotensin I Hydrolysis by Human Cardiac Enzymes Potentiate Bradykinin

Peter Deddish

Journal of Molecular and Cellular Cardiology, 2002

View PDFchevron_right

Type 2 Bradykinin-Receptor Antagonism Does Not Modify Kinin or Angiotensin Peptide Levels

Jialong Zhuo

Hypertension, 1999

View PDFchevron_right

Induction of Functional Bradykinin B1Receptors in Normotensive Rats and Mice Under Chronic Angiotensin-Converting Enzyme Inhibitor Treatment

Jean-Pierre Girolami

View PDFchevron_right

Do angiotensin-converting enzyme inhibitors directly stimulate the kinin B1 receptor?

Jean-Philippe Fortin

American journal of physiology. Heart and circulatory physiology, 2003

View PDFchevron_right

Neprilysin Inhibitors Potentiate Effects of Bradykinin on B2 Receptor

Peter Deddish, Zhenlong Chen

Hypertension, 2002

View PDFchevron_right

Localization of bradykinin B2 binding sites in rat kidney following chronic ACE inhibitor treatment

Jialong Zhuo

Kidney International, 1997

View PDFchevron_right

Effects of bradykinin B2 receptor antagonism on the hypotensive effects of ACE inhibition

Yves Joulin

British Journal of Pharmacology, 1994

View PDFchevron_right

Bradykinin receptors: Agonists, antagonists, expression, signaling, and adaptation to sustained stimulation

Jean-Philippe Fortin

International Immunopharmacology

View PDFchevron_right

Hypothesized and found mechanisms for potentiation of bradykinin actions

Siegmund Reissmann

Signal Transduction, 2006

View PDFchevron_right

Contribution of bradykinin to the cardioprotective effects of ACE inhibitors

Thomas Unger

European Heart Journal Supplements, 2003

View PDFchevron_right

Human ACE and bradykinin B2 receptors form a complex at the plasma membrane

Peter Deddish, Zhenlong Chen, ruo ning

FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2006

View PDFchevron_right

In vitro and in vivo effects of the new nonpeptide bradykinin B 2 receptor antagonist, LF 16-0335C, on guinea-pig and rat kinin receptors

Jean-Michel Luccarini

Fundamental & Clinical Pharmacology, 1999

View PDFchevron_right

Cardiovascular effects of intrathecally administered bradykinin in the rat: characterization of receptors with antagonists

P. Lopes

British Journal of Pharmacology, 1993

View PDFchevron_right

New agonist and antagonist analogues of bradykinin

P. D'Orléans-Juste

Canadian Journal of Physiology and Pharmacology, 1984

View PDFchevron_right

An in vitro reconstitution system to address the mechanism of the vascular expression of the bradykinin B1 receptor in response to angiotensin converting enzyme inhibition

François Marceau

Vascular Pharmacology, 2012

View PDFchevron_right

Heteromerization Between the Bradykinin B2 Receptor and the Angiotensin-(1-7) Mas Receptor: Functional Consequences

Bruno Cerrato

Hypertension, 2016

View PDFchevron_right

Potentiation of Bradykinin Effect by Angiotensin-Converting Enzyme Inhibition Does Not Correlate With Angiotensin-Converting Enzyme Activity in the Rat Mesenteric Arteries

Eduardo Aparecido de Oliveira

Hypertension, 2007

View PDFchevron_right

Nonpeptide Mimic of Bradykinin with Long-Acting Properties at the Bradykinin B2 Receptor

Hitoshi Kojo

Molecular Pharmacology, 1997

View PDFchevron_right

Selective Inhibition of the C-Domain of Angiotensin I Converting Enzyme by Bradykinin Potentiating Peptides

Philippe Cuniasse

Biochemistry, 2002

View PDFchevron_right

Angiotensin-(1–7) potentiates responses to bradykinin but does not change responses to angiotensin I

Syed Baber

Canadian Journal of Physiology and Pharmacology, 2006

View PDFchevron_right

Chronic inhibition of bradykinin B2-receptors enhances the slow vasopressor response to angiotensin II

M. Varoni

Hypertension, 1994

View PDFchevron_right

Icatibant, the bradykinin B2 receptor antagonist with target to the interconnected kinin systems

Christian Drouet, Delphine Charignon

Expert Opinion on Pharmacotherapy, 2012

View PDFchevron_right

A non-peptide antagonist unusually selective for the human form of the bradykinin B2 receptor

Jean-Philippe Fortin

International Immunopharmacology, 2003

View PDFchevron_right

Further pharmacological evaluation of a novel synthetic peptide bradykinin B2 receptor agonist

Julie Labonté

bchm, 2013

View PDFchevron_right

Antagonist-Induced Intracellular Sequestration of Rabbit Bradykinin B 2 Receptor

Dimcho Bachvarov

View PDFchevron_right

ACE Activity Is Modulated by Kinin B2 Receptor

Jair Gomes

2009

View PDFchevron_right

In vivo effects of bradykinin B2 receptor agonists with varying susceptibility to peptidases

François Marceau

View PDFchevron_right

Role of PGI2 and effects of ACE inhibition on the bradykinin potentiation by angiotensin-(1-7) in resistance vessels of SHR

D. Nigro

Regulatory Peptides, 2005

View PDFchevron_right

Vascular and sympathoadrenal responses to bradykinin and a bradykinin analogue

Rogerio Mulinari

Hypertension, 1988

View PDFchevron_right